Insider trade

Thermo Fisher Scientific (TMO)Officer sold ~$1.47M

Michel Lagarde, Officer at Thermo Fisher Scientific, sold ~$1.47M of Thermo Fisher Scientific shares.

~$1.47M
Approx. value · 2,521 sh @ $584.11
65K
Holds after · shares reported
Traded
Dec 3, 2025
Filed
Dec 4, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 23, 2024Congress · 1 personMembers of Congress: 2 purchases
  2. Apr 28, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  3. Jul 25, 2025CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  4. Sep 23, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  5. Oct 7, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  6. Oct 22, 2025Company filing · Form 8-K · ResultsReported its results
  7. Oct 24, 2025Insider · 2 peopleInsiders: 6 sales (~$10.0M)
  8. Oct 27, 2025Insider · 1 personInsiders: 11 sales (~$4.1M)
  9. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  10. Oct 31, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  11. Nov 7, 2025Insider · 1 personInsiders: 2 sales (~$5.8M)
  12. Nov 10, 2025Insider · 1 personInsiders: 2 sales (~$1.7M)
  13. Nov 12, 2025InsiderOfficer sold ~$622K of TMO shares in the open market
  14. Nov 13, 2025InsiderOfficer sold ~$2.76M of TMO shares in the open market
  15. Nov 24, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  16. Nov 25, 2025Insider · 1 personInsiders: 2 sales (~$6.4M)
  17. Dec 1, 2025InsiderOfficer sold ~$4.13M of TMO shares in the open market
  18. Dec 2, 2025Insider · 2 peopleInsiders: 2 sales (~$21.5M)
  19. Dec 3, 2025 · this disclosureInsiderOfficer sold ~$1.47M of TMO shares in the open market

What came next

  1. Dec 3, 2025InsiderOfficer sold ~$17.2M of TMO shares in the open market
  2. Dec 4, 2025InsiderOfficer sold ~$12.4M of TMO shares in the open market
  3. Dec 5, 2025FDAFDA device clearance: Thermo Scientific Oxoid Gepotidacin Disc (10 µg) GEP10
  4. Jan 12, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Each of Michel Lagarde and Frederick M. Lowery have notified Thermo Fisher Scientific Inc. (the “Company”) of their decisions to leave the Company to pursue other opportunities.”
  5. Jan 27, 2026Layoff notice · 5781 Van Allen Way Carlsbad CA 92008Layoff notice filed in CA: 173 employees
  6. Jan 29, 2026Company filing · Form 8-K · ResultsReported its results
  7. Feb 9, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  8. Feb 9, 2026InsiderOfficer sold ~$216K of TMO shares in the open market
  9. Mar 3, 2026Insider · 1 personInsiders: 12 sales (~$2.5M)
  10. Mar 4, 2026Insider · 1 personInsiders: 8 sales (~$2.6M)
  11. Mar 5, 2026Insider · 1 personInsiders: 13 sales (~$2.1M)
  12. Mar 11, 2026InsiderOfficer sold ~$803K of TMO shares in the open market
  13. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Thermo Fisher Scientific

For Thermo Fisher Scientific, OQRO holds 93 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 143 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMO page.

Other recent filings by Michel Lagarde, Executive Vice President & COO

The full history of Michel Lagarde, Executive Vice President & COO is on the profile page.

How this filing works

Other disclosures at Thermo Fisher Scientific

Everything OQRO holds on this company is on its TMO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data